Pharmaceutical Products
NME (New Molecule Entity) products
- JPI-289 (Stroke)- JPI-547 (Solid Tumors) - JP-1366 (GastroEsophageal Reflux Disease) - JP-2266 (Type I Diabetes Mellitus) - Stem Cell Therapy (Parkinson’s Disease / Age-related Macular Disease) IMD (Incrementally Modified Drug) products
- JLP-1207 (Benign Prostatic Hyperplasia)- JLP-1310 (Diabetes / Hyperlipidemia) - JLP-1401 (Hypertension / Hyperlipidemia) - JLP-1607 (Smoking Cessation Aid) Pipeline |
Technologies
 Synthesis of Active Pharmaceutical Ingredients (APIs)Formulation Technology |
| First Name * | |
| Last Name * | |
| Title * | |
| Company * | |
| Address 1 | |
| Address 2 | |
| City | |
| Country | |
| Postal Code | |
| E-mail Address * | |
| Phone * | |
| Fax | |
| Summary Description of Potential Opportunity * (2,000 character's limit) |
|
| Type of Business * | |
| * Required Field Submit Cancel |
|
